By browsing our site you agree to our use of cookies. You will only see this message once. Find out more
We regret to inform you that we have ceased publication of current announcements.
Unitedkingdom-tenders.co.uk domain is for sale. Please contact us.

NHS Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Scotland, Wales ...

Contract notice

Supplies

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
NHS England
2nd Floor, Rutland House
Runcorn
WA7 2ES
United Kingdom
E-mail:
NUTS code: UK

Internet address(es):

Main address: https://nhsengland.bravosolution.co.uk

I.2)Joint procurement
The contract is awarded by a central purchasing body
I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://nhsengland.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://nhsengland.bravosolution.co.uk
Tenders or requests to participate must be submitted to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at: https://nhsengland.bravosolution.co.uk
I.4)Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

NHS Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders.

Reference number: CM/PHS/15/5498
II.1.2)Main CPV code
33141530
II.1.3)Type of contract
Supplies
II.1.4)Short description:

NHS Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019, with options to extend up to a further 17 months. Please refer to the invitation of Offer documents for the list of Purchasing Points.

II.1.5)Estimated total value
Value excluding VAT: 302 000 000.00 GBP
II.1.6)Information about lots
This contract is divided into lots: yes
Tenders may be submitted for all lots
Maximum number of lots that may be awarded to one tenderer: 1
II.2)Description
II.2.1)Title:

Band A

Lot No: 1
II.2.2)Additional CPV code(s)
33141530
II.2.3)Place of performance
NUTS code: UK
II.2.4)Description of the procurement:

NHS National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The Framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019, with options to extend up to a further 17 months. Please refer to the invitation of Offer documents for the list of Purchasing Points.

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Start: 01/02/2018
End: 31/01/2019
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Band 2a

Lot No: 2
II.2.2)Additional CPV code(s)
33141530
II.2.3)Place of performance
NUTS code: UK
II.2.4)Description of the procurement:

NHS National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The Framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019, with options to extend up to a further 17 months. Please refer to the invitation of Offer documents for the list of Purchasing Points.

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Start: 01/02/2018
End: 31/01/2019
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Band 2b

Lot No: 3
II.2.2)Additional CPV code(s)
33141530
II.2.3)Place of performance
NUTS code: UK
II.2.4)Description of the procurement:

NHS National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The Framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019, with options to extend up to a further 17 months. Please refer to the invitation of Offer documents for the list of Purchasing Points.

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Start: 01/02/2018
End: 31/01/2019
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:

Band 3

Lot No: 4
II.2.2)Additional CPV code(s)
33141530
II.2.3)Place of performance
NUTS code: UK
II.2.4)Description of the procurement:

NHS National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland and may be used by private sector contractors and agents working on behalf of the above. The Framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019, with options to extend up to a further 17 months. Please refer to the invitation of Offer documents for the list of Purchasing Points.

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Start: 01/02/2018
End: 31/01/2019
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

Please refer to the award criteria contained in the Invitation to Offer.

III.1.2)Economic and financial standing
List and brief description of selection criteria:

Please refer to the award criteria contained in the Invitation to Offer.

III.1.3)Technical and professional ability
List and brief description of selection criteria:

Please refer to the award criteria contained in the Invitation to Offer.

III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
Framework agreement with several operators
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 22/09/2017
Local time: 13:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
English
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
IV.2.7)Conditions for opening of tenders
Date: 22/09/2017
Local time: 13:00
Place:

Runcorn, Cheshire.

Information about authorised persons and opening procedure:

Commercial Medicines Unit Employee.

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: no
VI.2)Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.3)Additional information:

Responding to this notice;

Any supplier may be disqualified who does not respond to the following in the requisite manner:

1) Submission of expression of interest and procurement specific information

This procurement exercise will be conducted on the eTendering portal at

www.nhsengland.bravosolution.co.uk. Candidates wishing to be considered for this procurement exercise

must register, and provide additional procurement specific information (if requested), through the

eTendering portal as follows:

1.1) If not already registered, Candidates should register on the eTendering portal at

https://www.nhsengland.bravosolution.co.uk and click the link to register:

- accept the terms and conditions and click continue,

- enter your correct business and user details,

- note the username you chose and click ‘Save’ when complete,

- you will shortly receive an email with your unique password (please keep this secure).

1.2) Once registered, candidates must express interest as follows:

a. login to the eTendering portal;

b. select ‘Response to ITT’;

c. select ‘ITTs Open To All Suppliers’;

d. access listing related to this procurement NHS National Framework Agreement for the supply of

Recombinant Factor VIII products and view details;

e. click on ‘Express interest’ button at the top of the page.

f. Once you have expressed interest, the ITT will move to ‘My ITTs’, where you can download additional

documentation (if required), and construct your reply as instructed. You must then publish your reply using

the ‘Publish’ button.

1.3) For any support in registering on the portal or submitting your expression of interest please contact

the eTendering Help-desk at +44 800 368 4850 or .

2) General supplier information.

To manage and assess supplier information the Contracting Authority requests candidates provide their

company profile in the Governments supplier information database, sid4gov, as follows:

2.1) If not already registered, Candidates must go to the following web page

https://sid4gov.cabinetoffice.gov.uk/ and select ‘Register for sid4gov’ at the bottom of the page. Key in

details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link

at the right of the page to obtain a number from D&B. Candidates must obtain a Dun & Bradstreet (D&B) DU-

N-S® Number to enable registration on sid4gov.

2.2) Once registration is complete you are able to create and update your sid4gov company profile.

Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for

each procurement exercise. D&B data will be supplied automatically by D&B.

2.3) For further help or information concerning sid4gov, please contact the sid4gov Helpdesk at:

or telephone +44 (0) 845 299 2994.

The framework agreement is for the benefit of other participating NHS bodies (whether acting individually,

or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the

participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other

government departments or non-departmental public bodies charged with the delivery of healthcare or

health related services.

VI.4)Procedures for review
VI.4.1)Review body
The NHS Commissioning Board (operating under the name of NHS England)
Runcorn
United Kingdom
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained
VI.5)Date of dispatch of this notice:
17/08/2017